What is the mechanism behind increased permeation rate of a poorly soluble drug from aqueous dispersions of an amorphous solid dispersion?

Our aim was to explore the influence of micelles and microparticles emerging in aqueous dispersions of amorphous solid dispersions (ASDs) on molecular/apparent solubility and Caco-2 permeation. The ASD, prepared by hot-melt extrusion, contained the poorly soluble model drug ABT-102, a hydrophilic po...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Frank, Kerstin J. (VerfasserIn) , Westedt, Ulrich (VerfasserIn) , Rosenblatt, Karin M. (VerfasserIn) , Hölig, Peter (VerfasserIn) , Rosenberg, Jörg (VerfasserIn) , Mägerlein, Markus (VerfasserIn) , Fricker, Gert (VerfasserIn) , Brandl, Martin (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 2014
In: Journal of pharmaceutical sciences
Year: 2016, Jahrgang: 103, Heft: 6, Pages: 1779-1786
ISSN:1520-6017
DOI:10.1002/jps.23979
Online-Zugang:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1002/jps.23979
Verlag, lizenzpflichtig, Volltext: http://www.sciencedirect.com/science/article/pii/S0022354915305682
Volltext
Verfasserangaben:Kerstin J. Frank, Ulrich Westedt, Karin M. Rosenblatt, Peter Hölig, Jörg Rosenberg, Markus Mägerlein, Gert Fricker, Martin Brandl

MARC

LEADER 00000caa a2200000 c 4500
001 1727346491
003 DE-627
005 20230427022633.0
007 cr uuu---uuuuu
008 200818r20142016xx |||||o 00| ||eng c
024 7 |a 10.1002/jps.23979  |2 doi 
035 |a (DE-627)1727346491 
035 |a (DE-599)KXP1727346491 
035 |a (OCoLC)1341355830 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Frank, Kerstin J.  |e VerfasserIn  |0 (DE-588)1042228116  |0 (DE-627)768470552  |0 (DE-576)39378441X  |4 aut 
245 1 0 |a What is the mechanism behind increased permeation rate of a poorly soluble drug from aqueous dispersions of an amorphous solid dispersion?  |c Kerstin J. Frank, Ulrich Westedt, Karin M. Rosenblatt, Peter Hölig, Jörg Rosenberg, Markus Mägerlein, Gert Fricker, Martin Brandl 
264 1 |c 2014 
300 |a 8 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Available online 3 January 2016 
500 |a Gesehen am 18.08.2020 
520 |a Our aim was to explore the influence of micelles and microparticles emerging in aqueous dispersions of amorphous solid dispersions (ASDs) on molecular/apparent solubility and Caco-2 permeation. The ASD, prepared by hot-melt extrusion, contained the poorly soluble model drug ABT-102, a hydrophilic polymer, and three surfactants. Aqueous dispersions of the ASD were investigated at two concentrations, one above and one close to the critical micelle concentration of the surfactants blend in the extrudate. Micelles were detected at the higher concentration and no micelles at the lower concentration. Apparent solubility of ABT-102 was 20-fold higher in concentrated than in diluted dispersions, because of micelles. In contrast, Caco-2 permeation of ABT-102 was independent of the ASD concentration, but three times faster than that of crystalline suspensions. Molecular solubility of ABT-102 (equilibrium dialysis) was also independent of the ASD concentration, but by a factor 2 higher than crystalline ABT-102. The total amount of ABT-102 accumulated in the acceptor during Caco-2 experiments exceeded the initial amount of molecularly dissolved drug in the donor. This may indicate that dissolution of amorphous microparticles present in aqueous dispersions induces lasting supersaturation maintaining enhanced permeation. The hypothesis is supported by a slower drug permeation when the microparticles were removed. © 2014 Wiley Periodicals, Inc. and the American Pharmacists Association J Pharm Sci 103:1779-1786, 2014 
534 |c 2016 
650 4 |a amorphous 
650 4 |a microparticles 
650 4 |a permeability 
650 4 |a solid dispersion 
650 4 |a solubility 
650 4 |a supersaturation 
700 1 |a Westedt, Ulrich  |e VerfasserIn  |4 aut 
700 1 |a Rosenblatt, Karin M.  |e VerfasserIn  |4 aut 
700 1 |a Hölig, Peter  |e VerfasserIn  |4 aut 
700 1 |a Rosenberg, Jörg  |e VerfasserIn  |4 aut 
700 1 |a Mägerlein, Markus  |e VerfasserIn  |4 aut 
700 1 |a Fricker, Gert  |d 1956-  |e VerfasserIn  |0 (DE-588)1042227675  |0 (DE-627)768469465  |0 (DE-576)393783464  |4 aut 
700 1 |a Brandl, Martin  |e VerfasserIn  |4 aut 
773 0 8 |i Enthalten in  |t Journal of pharmaceutical sciences  |d Amsterdam : Elsevier, 1911  |g 103(2014), 6, Seite 1779-1786  |h Online-Ressource  |w (DE-627)302718028  |w (DE-600)1491821-3  |w (DE-576)090855167  |x 1520-6017  |7 nnas  |a What is the mechanism behind increased permeation rate of a poorly soluble drug from aqueous dispersions of an amorphous solid dispersion? 
773 1 8 |g volume:103  |g year:2014  |g number:6  |g pages:1779-1786  |g extent:8  |a What is the mechanism behind increased permeation rate of a poorly soluble drug from aqueous dispersions of an amorphous solid dispersion? 
856 4 0 |u https://doi.org/10.1002/jps.23979  |x Verlag  |x Resolving-System  |z lizenzpflichtig  |3 Volltext 
856 4 0 |u http://www.sciencedirect.com/science/article/pii/S0022354915305682  |x Verlag  |z lizenzpflichtig  |3 Volltext 
951 |a AR 
992 |a 20200818 
993 |a Article 
994 |a 2014 
998 |g 1042227675  |a Fricker, Gert  |m 1042227675:Fricker, Gert  |d 160000  |d 160100  |e 160000PF1042227675  |e 160100PF1042227675  |k 0/160000/  |k 1/160000/160100/  |p 7 
998 |g 1042228116  |a Frank, Kerstin J.  |m 1042228116:Frank, Kerstin J.  |p 1  |x j 
999 |a KXP-PPN1727346491  |e 3740744251 
BIB |a Y 
SER |a journal 
JSO |a {"title":[{"title_sort":"What is the mechanism behind increased permeation rate of a poorly soluble drug from aqueous dispersions of an amorphous solid dispersion?","title":"What is the mechanism behind increased permeation rate of a poorly soluble drug from aqueous dispersions of an amorphous solid dispersion?"}],"person":[{"display":"Frank, Kerstin J.","roleDisplay":"VerfasserIn","role":"aut","given":"Kerstin J.","family":"Frank"},{"display":"Westedt, Ulrich","given":"Ulrich","role":"aut","roleDisplay":"VerfasserIn","family":"Westedt"},{"role":"aut","roleDisplay":"VerfasserIn","given":"Karin M.","display":"Rosenblatt, Karin M.","family":"Rosenblatt"},{"display":"Hölig, Peter","role":"aut","roleDisplay":"VerfasserIn","given":"Peter","family":"Hölig"},{"family":"Rosenberg","display":"Rosenberg, Jörg","roleDisplay":"VerfasserIn","role":"aut","given":"Jörg"},{"display":"Mägerlein, Markus","roleDisplay":"VerfasserIn","role":"aut","given":"Markus","family":"Mägerlein"},{"family":"Fricker","given":"Gert","roleDisplay":"VerfasserIn","role":"aut","display":"Fricker, Gert"},{"roleDisplay":"VerfasserIn","role":"aut","given":"Martin","display":"Brandl, Martin","family":"Brandl"}],"language":["eng"],"id":{"eki":["1727346491"],"doi":["10.1002/jps.23979"]},"name":{"displayForm":["Kerstin J. Frank, Ulrich Westedt, Karin M. Rosenblatt, Peter Hölig, Jörg Rosenberg, Markus Mägerlein, Gert Fricker, Martin Brandl"]},"physDesc":[{"extent":"8 S."}],"origin":[{"dateIssuedKey":"2014","dateIssuedDisp":"2014"}],"relHost":[{"pubHistory":["1.1911 -"],"type":{"media":"Online-Ressource","bibl":"periodical"},"note":["Gesehen am 07.02.13"],"recId":"302718028","part":{"pages":"1779-1786","year":"2014","extent":"8","text":"103(2014), 6, Seite 1779-1786","issue":"6","volume":"103"},"id":{"eki":["302718028"],"zdb":["1491821-3"],"doi":["10.1002/(ISSN)1520-6017"],"issn":["1520-6017"]},"titleAlt":[{"title":"Journal of the American Pharmaceutical Association"}],"origin":[{"publisher":"Elsevier ; American Chemical Society and American Pharmaceutical Association ; Wiley","dateIssuedDisp":"1911-","publisherPlace":"Amsterdam ; Washington, DC [u.a.] ; New York, NY","dateIssuedKey":"1911"}],"physDesc":[{"extent":"Online-Ressource"}],"name":{"displayForm":["American Chemical Society"]},"language":["eng"],"disp":"What is the mechanism behind increased permeation rate of a poorly soluble drug from aqueous dispersions of an amorphous solid dispersion?Journal of pharmaceutical sciences","title":[{"title_sort":"Journal of pharmaceutical sciences","title":"Journal of pharmaceutical sciences"}]}],"note":["Available online 3 January 2016","Gesehen am 18.08.2020"],"recId":"1727346491","type":{"bibl":"article-journal","media":"Online-Ressource"}} 
SRT |a FRANKKERSTWHATISTHEM2014